The short explanation
A sister diagnosed at 38 is a significant family history, and it is sensible for the rest of you to plan. The first step is usually to ask your sister's treating team whether genetic testing, such as for BRCA1 and BRCA2, is recommended for her. Testing the person with cancer first gives the clearest answer for the family. If she carries a gene change, the rest of you can then be tested for that specific change. If she does not, your screening plan will still take her young age at diagnosis into account.
What depends on your situation
The parts of this that change from woman to woman. Uncertainty is stated, not hidden.
- Until then, each of you can see a doctor to discuss when to start screening. Women with a close relative diagnosed young are often advised to begin earlier than usual, sometimes with yearly imaging. Mention any other relatives with breast, ovarian, pancreatic or prostate cancer.
- This is also a hard time emotionally. Supporting your sister through treatment while worrying about yourselves is a lot to carry. Cancer hospitals often have counsellors and support groups for families.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- This answer cannot tell any of you your personal risk. That needs a doctor or genetic counsellor to review the full history.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- Should my sister be offered genetic testing?
- When should I start screening, and with which test?
- Do I need a referral to a genetic counsellor?
- What support is there for families?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Book an appointment soon
- See a clinician within a couple of weeks if any of you notices a breast lump or change.
Raise it at a routine appointment
- Each sister can book a routine visit to discuss screening and genetic counselling.
Sources
The evidence this explanation is built on.
- BRCA gene changes: cancer risk and genetic testing National Cancer Institute
- Breast cancer MedlinePlus (NIH)
- Breast cancer World Health Organization
Who wrote and reviewed this
Every AskHer answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHer Editorial (AI-assisted) AskHer's editorial team — not an individual clinician Works in English, தமிழ், हिन्दी
- Clinical reviewer
- Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHer’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
- Review status
- Editorially reviewed
- Last reviewed
- Last reviewed 11 November 2026
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.

